Journal of Contemporary ISTDP

Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDP

Journal of Contemporary ISTDP March 14, 2025 Thomas Hesslow

Psychedelic science is growing at a rapid pace, and as evidence accrues, we will most likely see authorization of the use of substances such as psilocybin and MDMA augmenting the effects of psychotherapy in the coming years. Lykos therapeutics (previously called MAPS PBC) recently filed a New Drug Application to the FDA in the US and expects to be able to offer MDMA as a prescribable drug in...